Cargando…

A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial

BACKGROUND: There is no consensus agreement regarding optimal management of locally excised ductal carcinoma in situ (DCIS) or features of greatest assistance in predicting disease behaviour. Cases in the UKCCCR/ANZ DCIS trial have been histologically reviewed to determine the features of prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinder, S E, Duggan, C, Ellis, I O, Cuzick, J, Forbes, J F, Bishop, H, Fentiman, I S, George, W D
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905282/ https://www.ncbi.nlm.nih.gov/pubmed/20517310 http://dx.doi.org/10.1038/sj.bjc.6605718

Ejemplares similares

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial
por: Cuzick, Jack, et al.
Publicado: (2010)

Prognostic and Predictive Value of HER2 Expression in Ductal Carcinoma In Situ: Results from the UK/ANZ DCIS Randomized Trial
por: Thorat, Mangesh A., et al.
Publicado: (2021)

Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence
por: Barnes, N, et al.
Publicado: (2006)

Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease
por: Clark, S E, et al.
Publicado: (2011)

The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS
por: Wallis, M G, et al.
Publicado: (2012)

Is palpable DCIS more aggressive than screen-detected DCIS?
por: Balac, Nina, et al.
Publicado: (2022)

Microcalcification crystallography as a potential marker of DCIS recurrence
por: Gosling, Sarah B., et al.
Publicado: (2023)

Biological Markers Predictive of Invasive Recurrence in DCIS
por: Nofech-Mozes, Sharon, et al.
Publicado: (2008)

Low-risk DCIS. What is it? Observe or excise?
por: Pinder, Sarah E., et al.
Publicado: (2021)

Clinicopathological characteristics and prognostic analysis of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ (DCIS) and DCIS with microinvasion (DCIS-Mi) of the breast
por: Jia, Huiqing, et al.
Publicado: (2022)

Imaging features of noncalcified DCIS
por: Scudder, JM, et al.
Publicado: (2012)

Derivation of a nuclear heterogeneity image index to grade DCIS
por: Hayward, Mary-Kate, et al.
Publicado: (2020)

Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast
por: Teo, N B, et al.
Publicado: (2002)

Ductal carcinoma in situ (DCIS): the role of prognostic indicators in informing treatment and reducing local recurrence
por: Clements, K, et al.
Publicado: (2004)

Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002)

Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions
por: Bergholtz, Helga, et al.
Publicado: (2020)

Ductal Carcinoma In Situ (DCIS) and Microinvasive DCIS: Role of Surgery in Early Diagnosis of Breast Cancer
por: Magnoni, Francesca, et al.
Publicado: (2023)

Grading Ductal Carcinoma In Situ (DCIS) of the Breast – What’s Wrong with It?
por: Cserni, Gábor, et al.
Publicado: (2019)

Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies
por: Rakovitch, E., et al.
Publicado: (2018)

Growth pattern of ductal carcinoma in situ (DCIS): a retrospective analysis based on mammographic findings
por: Thomson, J Z, et al.
Publicado: (2001)

Boost und Hypofraktionierung beim DCIS
por: Dunst, Jürgen, et al.
Publicado: (2022)

Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma
por: Jones, R L, et al.
Publicado: (2006)

Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review
por: Lari, Sara A., et al.
Publicado: (2011)

γ-Glutamyl transferase and breast cancer risk
por: Fentiman, I S, et al.
Publicado: (2010)

Pure low-grade DCIS in a male patient: a case report
por: Zaesim, Araya, et al.
Publicado: (2018)

Ductal carcinoma in situ (DCIS): are we overdetecting it?
por: Evans, A
Publicado: (2004)

Ductal carcinoma in situ (DCIS): are we overtreating it?
por: Dixon, JM
Publicado: (2004)

MJRA1.9 - AAI requirements of DCIs
Publicado: (Nove)

Educational Case: Ductal Carcinoma In Situ (DCIS)
por: Komforti, Miglena K., et al.
Publicado: (2019)

Countercurrents: DCIS or Cancer? Why All the Confusion?
por: Narod, Steven A., et al.
Publicado: (2022)

Identifying a Highly-Aggressive DCIS Subgroup by Studying Intra-Individual DCIS Heterogeneity among Invasive Breast Cancer Patients
por: Pape-Zambito, Dana, et al.
Publicado: (2014)

Quality of DCIS information on the internet: a content analysis
por: Blackwood, Jayden, et al.
Publicado: (2019)

Functional analysis of normal and DCIS modified breast myoepithelial cells
por: Allen, M, et al.
Publicado: (2006)

Ipsilateral Recurrence of DCIS in Relation to Radiomics Features on Contrast Enhanced Breast MRI
por: Park, Ga Eun, et al.
Publicado: (2022)

Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised study
por: Holmberg, L, et al.
Publicado: (2013)

Trends and predictors of size and grade for ductal carcinoma in situ (DCIS) in BreastScreen Victoria
por: Erbas, B, et al.
Publicado: (2004)

The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions
por: Terry, G, et al.
Publicado: (2007)

Sentinel Lymph Node Biopsy in Pure DCIS: Is It Necessary?
por: Boler, D. E., et al.
Publicado: (2012)

DCIS and axillary nodal evaluation: compliance with national guidelines
por: Mitchell, Katrina B., et al.
Publicado: (2017)

Is anti-hormonal treatment in DCIS of the breast a need?
por: Tjalma, WAA
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8ad3jotkfnp0f9jtgmik2bijb7